Volitionrx (VNRX) Cash from Financing Activities (2011 - 2025)

Volitionrx's Cash from Financing Activities history runs 15 years deep, the most recent figure standing at $6.2 million for Q4 2025.

• Quarterly Cash from Financing Activities rose 168.83% year-over-year to $6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17.1 million (up 97.44% YoY) and the FY2025 annual result came in at $17.1 million, up 97.44% from the prior year.
• Cash from Financing Activities was $6.2 million for Q4 2025 at Volitionrx, up from $1.6 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $20.2 million in Q1 2021 and bottomed at -$460198.0 in Q2 2022.
• A 5-year average of $4.2 million and a median of $2.2 million in 2021 frame the typical range for Cash from Financing Activities.
• Peak annual rise in Cash from Financing Activities reached 13203.23% in 2022, while the deepest fall reached 191.81% in 2022.
• Volitionrx's Cash from Financing Activities stood at $2.1 million in 2021, then slumped by 55.85% to $925964.0 in 2022, then soared by 307.19% to $3.8 million in 2023, then slumped by 39.27% to $2.3 million in 2024, then jumped by 168.83% to $6.2 million in 2025.
• Business Quant data shows VNRX's Cash from Financing Activities at $6.2 million in Q4 2025, $1.6 million in Q3 2025, and $5.7 million in Q2 2025.